Cargando…
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
Glioblastoma multiforme (GBM) universally recurs with dismal prognosis. We evaluated the efficacy of standard treatment strategies for patients with recurrent GBM (rGBM). From two centers in the Netherlands, 299 patients with rGBM after first-line treatment, diagnosed between 2005 and 2014, were ret...
Autores principales: | van Linde, Myra E., Brahm, Cyrillo G., de Witt Hamer, Philip C., Reijneveld, Jaap C., Bruynzeel, Anna M. E., Vandertop, W. Peter, van de Ven, Peter M., Wagemakers, Michiel, van der Weide, Hiske L., Enting, Roelien H., Walenkamp, Annemiek M. E., Verheul, Henk M. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658463/ https://www.ncbi.nlm.nih.gov/pubmed/28730289 http://dx.doi.org/10.1007/s11060-017-2564-z |
Ejemplares similares
-
The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review
por: Brahm, Cyrillo G., et al.
Publicado: (2020) -
Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma
por: Brahm, Cyrillo G, et al.
Publicado: (2020) -
Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study
por: Brahm, Cyrillo G., et al.
Publicado: (2018) -
(11)C-methyl-L-methionine PET measuring parameters for the diagnosis of tumour progression against radiation-induced changes in brain metastases
por: Govaerts, Chris W., et al.
Publicado: (2021) -
Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach
por: Conroy, Siobhan, et al.
Publicado: (2014)